Stay updated on Tiragolumab Combo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.

Latest updates to the Tiragolumab Combo in Stage II Melanoma Clinical Trial page
- ChecktodayChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check7 days agoChange DetectedA notice was added announcing NIH website changes and explaining that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference0.7%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry (v3.7.0) was added to the record history, and the older revision (v3.6.6) was removed from the list. This updates the visible history to reflect the latest versioning of the study record.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now shows a new revision entry v3.6.6 and removes the previous revision v3.6.5, indicating an administrative update to the record.SummaryDifference0.1%

Stay in the know with updates to Tiragolumab Combo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in Stage II Melanoma Clinical Trial page.